AI MARKET SCANNING

$DYN

Dyne Therapeutics Inc

United StatesUNITED STATES
FREE PREVIEW
🌐 Website🏛️ NASDAQ📁 Health Technology🏭 Biotechnology
AVG HISTORICAL GAP-0.65%
MAX GAP RECORD-5.38%
PREMIUM
AI ACCURACY RATE
92.4%
Unlock AI Insights 🔓

LAST 10 EARNINGS GAPS (%)

QUANTITATIVE LIVE RADAR BLOTTER

Institutional execution stream for $DYN

EXECUTIONS0
WIN RATE••.•%
NET ROI+•••.••%
Execution DateStrategy & SetupDirectionExecution RangeHold TimeExit TriggerNet PnL
RADAR SCANNING: WAITING FOR NEXT CATALYST
🔒 Institutional Data Protected

Exact execution prices, stop-loss triggers, and full trade logs are reserved for PRO members.

UNLOCK FULL BLOTTER

VOLATILITY & BIAS PROFILE

AVG VOLATILITY1.7%
Bullish Gaps
Bearish Gaps
Neutral

Intelligence Brief

Dyne Therapeutics, Inc. is a clinical-stage company, which engages in developing innovative life-transforming therapies for genetically driven muscle diseases. It develops a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral muscular dystrophy. The company was founded by Jason P. Rhodes and Romesh R. Subramanian on December 1, 2017… Read full dossier

CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL

AI INSIGHTS & REPORTS FOR $DYN

AI REPORT
Sep 13

This Week in Quant: A Deeper Dive into Market Dynamics

AnalysisMarkets this week exhibited a mix of volatility and strategic positioning as participants adapted to shifting macroeconomic signals.…
VIEW REPORT_
AI REPORT
Aug 24

WDS Earnings Gap Anticipation: A Deep Dive into Market Dynamics

Analysis Markets have been buzzing with anticipation ahead of the upcoming earnings report for $WDS, a key player…
VIEW REPORT_
AI REPORT
Aug 12

Deep Dive into Market Dynamics: Analyzing Ticker Movements

Analysis Markets have shown heightened volatility recently, driven by shifting sentiment and macroeconomic factors. The 15% earnings growth…
VIEW REPORT_